MORFFI
DEAD

Serial Number

87222158

Owner

BBI SOLUTIONS OEM LIMITED

Attorney

Nicole M. Meyer

Filing Date

Nov 1, 2016

Add to watchlist:

No watchlists yet
View on USPTO

MORFFI Trademark

Serial Number: 87222158 • Registration: 5578007

MORFFI is a trademark filed by BBI SOLUTIONS OEM LIMITED on November 1, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

BBI SOLUTIONS OEM LIMITED (9 trademarks)

THE COURTYARD, 73 TY GLAS AVENUE
CARDIFF, SOUTH GLAMORGAN CF14 5DX , GB

Entity Type: 11

Trademark Details

Filing Date

November 1, 2016

Registration Date

October 9, 2018

Published for Opposition

January 16, 2018

Cancellation Date

April 25, 2025

Goods & Services

Custom manufacturing services of goods relating to conjugate blocking technology; custom manufacturing services of goods relating to assays and lateral flow assays and enhancement and performance of lateral flow assays

Chemicals and chemical reagents for medical use; chemicals, reagents, chemical preparations, and chemical substances all for use in analysis and testing in laboratories for medical and medical diagnostic purposes; reagents in kit form for performing assays for diagnostic and medical purposes; diagnostic reagents for diagnostic and medical use; proteins for diagnostic and medical use; cell culture proteins for diagnostic and medical use; monoclonal antibodies for diagnostic and medical use; enzymes for diagnostic and medical use; albumin for diagnostic and medical use; human and animal blood plasma; chemicals agents for use in separation for diagnostic and medical use; cell culture media for use in separation techniques for diagnostic and medical use

Chemical products in the nature of chemicals for use in industry and science; chemicals and chemical reagents for non-medical laboratory use; chemicals, reagents, immunoassay preparations and substances for testing blood, bodily fluids samples, antibodies and purified agents for diagnostic purposes; chemicals, reagents, chemical preparations, and chemical substances all for use in analysis and testing in laboratories other than for medical or veterinary purposes; reagents in kit form for performing assays for scientific and research use; chemical substances and immunoassays in the nature of assays for use in diagnostic kits for research purposes; diagnostic reagents for scientific and research use; exogenous antigen, endogenous antigen and autoantigen agents for activating cellular functions; proteins for scientific and research use; immunoassays in the nature of chemical tests used to detect or quantify analytes using an immunological reaction; cell culture proteins for scientific and research use; monoclonal antibodies for in vitro scientific and research use; antigens, namely, exogenous antigens, endogenous antigens, and autoantigens for scientific and medical research use; enzymes for in vitro, scientific, and research use; transferrin, namely, glycoproteins; albumin for scientific and research purposes; human antigens, namely, exogenous antigens, endogenous antigens, and autoantigens for scientific and medical research use; human and animal plasma for scientific and medical research use; human and animal serum, namely, albumin and bovine serum for scientific and medical research use; chemical agents for use in separation for scientific and research use; cell culture media for use in separation techniques for scientific and research use; chemicals and chemical reagents for diagnostic laboratory use

Scientific and technological development services and research and design relating thereto in the field of lateral flow immunoassays and conjugate blocking technology; scientific and technological services, namely, custom conjugation, lateral flow assay development, lateral flow assay creation, and research and design relating to conjugate blocking technology; scientific and technological services, namely, design and research relating to lateral flow conjugation processes; scientific and technological services, namely, design and research relating to the enhancement and performance of lateral flow assays; industrial analysis and research services for the enhancement and performance of lateral flow assays; diagnostic and medical laboratory services; chemical analysis and research for others; diagnostic medical testing for medical, scientific and research purposes; diagnostic medical testing relating to assays for diagnostic, medical and research purposes; diagnostic medical testing relating to conjugate blocking technology for diagnostic, medical, scientific and technological purposes; custom design and formulation in the nature of research, development, product evaluation of chemicals, assays and reagents for the diagnostics industry; custom design and formulation in the nature of research, development, product evaluation of chemicals, assays and reagents for separation and purification techniques; research and analysis for the diagnostics industry; technological services, namely, reading of results, processing of results, technical information, data sheets, and brochures relating to assays and lateral flow assays; technological and scientific research services relating to assays and lateral flow assays; lateral flow development of assays and lateral flow diagnostic testing services for medical, scientific and research purposes; development of lateral flow assays, lateral flow immunoassays and research into conjugate blocking technology; advisory, information and consultancy services relating to all of the aforesaid

Filing History

CANCELLED SEC. 8 (6-YR)
Apr 25, 2025 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 9, 2023 REM1
REGISTERED-PRINCIPAL REGISTER
Oct 9, 2018 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Aug 30, 2018 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 30, 2018 AITU
NOTICE OF ALLOWANCE CANCELLED
Jul 17, 2018 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
Jul 17, 2018 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 13, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 16, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jan 16, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 27, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 8, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 7, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 7, 2017 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 7, 2017 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 24, 2017 GNFN
FINAL REFUSAL E-MAILED
Oct 24, 2017 GNFR
FINAL REFUSAL WRITTEN
Oct 24, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 7, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 7, 2017 CRFA
TEAS VOLUNTARY AMENDMENT RECEIVED
Sep 1, 2017 PARI
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 28, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 28, 2017 CRFA
ASSIGNED TO LIE
Aug 24, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 4, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 9, 2017 GNRN
NON-FINAL ACTION E-MAILED
Feb 9, 2017 GNRT
NON-FINAL ACTION WRITTEN
Feb 9, 2017 CNRT
ASSIGNED TO EXAMINER
Feb 8, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 4, 2016 NWOS
NEW APPLICATION ENTERED
Nov 4, 2016 NWAP